Ignite Creation Date:
2024-05-06 @ 2:51 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04443036
Status:
UNKNOWN
Last Update Posted:
2020-06-23
First Post:
2020-06-19
Brief Title:
Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic GGEJ Carcinoma
Sponsor:
China Medical University China
Organization:
China Medical University China
Study Overview
Official Title:
Albumin-bound Paclitaxel Combined With Toripalimab as First-lineSecond-line Treatment of Local Advanced or Metastatic Gastric or Gastroesophageal Junction Carcinoma A Prospective Open-label Single-arm Phase II Clinical Study
Status:
UNKNOWN
Status Verified Date:
2020-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to evaluate the efficacy and safety of Albumin-bound paclitaxel combined with Toripalimab as first-linesecond-line treatment of local advanced or metastatic gastric or gastroesophageal junction carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None